Benzer Haberler
Frontier IP scores on sale of Exscientia shares
Early-stage investor Frontier IP has booked a seven-figure profit on the sale of stock in Exscientia, a spin-out firm from the University of Dundee that uses artificial intelligence (AI) to help pharmaceutical companies speed up the way new medicines are discovered and developed.
The, Doctor
33
